VolitionRx Limited Net Income (Loss) Attributable to Noncontrolling Interest
VolitionRx Limited (VNRX) reported Net Income (Loss) Attributable to Noncontrolling Interest of $10.78 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-13
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was $10.78K.
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$38.78K.
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for the quarter ending 2025-06-30 was -$29.99K, a 140.19% decline year-over-year.
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for the quarter ending 2025-03-31 was -$52.87K.
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$290.15K.
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for fiscal 2023 was -$358.00K, a 208.59% decline from fiscal 2022.
- VolitionRx Limited net income (loss) attributable to noncontrolling interest for fiscal 2022 was $329.68K.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10.78K 10-Q · filed 2026-08-13 | -$28.00K 10-Q · filed 2026-08-13 | ||||
| 2026-03-31 | -$38.78K 10-Q · filed 2026-05-14 | |||||
| 2025-06-30 | -$29.99K 10-Q · filed 2026-08-13 | -$82.86K 10-Q · filed 2026-08-13 | -$146.71K derived: sum of 3 quarters · filed 2026-08-13 | -$193.76K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$52.87K 10-Q · filed 2026-05-14 | -$116.72K derived: sum of 2 quarters · filed 2026-05-14 | -$163.77K derived: sum of 3 quarters · filed 2026-05-14 | -$89.14K derived: sum of 4 quarters · filed 2026-05-14 | ||
| 2024-12-31 | -$63.85K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$110.90K derived: sum of 2 quarters · filed 2025-03-31 | -$36.27K derived: sum of 3 quarters · filed 2025-03-31 | -$290.15K 10-K · filed 2025-03-31 | ||
| 2024-09-30 | -$47.05K 10-Q · filed 2024-11-14 | $27.58K derived: sum of 2 quarters · filed 2024-11-14 | -$226.29K 10-Q · filed 2024-11-14 | -$178.49K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2024-06-30 | $74.63K 10-Q · filed 2024-08-14 | $179.25K 10-Q · filed 2024-08-14 | -$131.44K derived: sum of 3 quarters · filed 2025-05-15 | -$214.32K derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2024-03-31 | -$104.62K 10-Q · filed 2025-05-15 | $104.62K 10-Q · filed 2024-05-13 | -$206.07K derived: sum of 2 quarters · filed 2025-05-15 | -$288.95K derived: sum of 3 quarters · filed 2025-05-15 | -$208.66K derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | -$101.45K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$184.34K derived: sum of 2 quarters · filed 2025-03-31 | -$104.04K derived: sum of 3 quarters · filed 2025-03-31 | -$358.00K 10-K · filed 2025-03-31 | $358.00K 10-K · filed 2024-03-25 | |
| 2023-09-30 | -$82.89K 10-Q · filed 2024-11-14 | -$2.59K derived: sum of 2 quarters · filed 2024-11-14 | -$256.55K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $80.30K 10-Q · filed 2024-08-14 | $173.66K 10-Q · filed 2024-08-14 | ||||
| 2023-03-31 | $93.36K 10-Q · filed 2024-05-13 | -$93.36K 10-Q · filed 2023-05-10 | ||||
| 2022-12-31 | $329.68K 10-K · filed 2024-03-25 | |||||
| 2022-06-30 | $82.30K 10-Q · filed 2023-08-14 | $166.28K 10-Q · filed 2023-08-14 | ||||
| 2022-03-31 | -$83.98K 10-Q · filed 2023-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |